Old Web
English
Sign In
Acemap
>
authorDetail
>
Outi Mäki-Ikola
Outi Mäki-Ikola
Orion Corporation
Selegiline
Pharmacology
Medicine
Anesthesia
Endocrinology
4
Papers
93
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Deramciclane in the treatment of generalized anxiety disorder: A placebo-controlled, double-blind, dose-finding study
2005
European Neuropsychopharmacology
Hannu Naukkarinen
Roope Raassina
Jukka Penttinen
Antti Ahokas
Riitta Jokinen
Hannu Koponen
Ulla Lepola
Harri Kanerva
Leena Lehtonen
Tiina Pohjalainen
Auli Partanen
Outi Mäki-Ikola
Juha Rouru
Show All
Source
Cite
Save
Citations (17)
Multiple-dose pharmacokinetics of selegiline and desmethylselegiline suggest saturable tissue binding.
2000
Clinical Neuropharmacology
Kari Laine
Markku Anttila
Risto Huupponen
Outi Mäki-Ikola
Esa Heinonen
Show All
Source
Cite
Save
Citations (29)
Lack of Adverse Interactions Between Concomitantly Administered Selegiline and Citalopram
1997
Clinical Neuropharmacology
Kari Laine
Markku Anttila
Esa Heinonen
Antti Helminen
Risto Huupponen
Outi Mäki-Ikola
K. Reinikainen
Mika Scheinin
Show All
Source
Cite
Save
Citations (47)
Long-Term Safety and Efficacy of Selegiline in the Treatment of Parkinson’s Disease
1997
Outi Mäki-Ikola
Esa Heinonen
Risto Lammintausta
Show All
Source
Cite
Save
Citations (0)
1